VeriStar Capital Management LP Purchases 3,539 Shares of Humana Inc. (NYSE:HUM)

VeriStar Capital Management LP grew its holdings in Humana Inc. (NYSE:HUM - Free Report) by 16.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,239 shares of the insurance provider's stock after acquiring an additional 3,539 shares during the period. Humana accounts for 10.7% of VeriStar Capital Management LP's portfolio, making the stock its 3rd largest holding. VeriStar Capital Management LP's holdings in Humana were worth $6,403,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Pinnacle Wealth Management Advisory Group LLC boosted its holdings in shares of Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after purchasing an additional 37 shares during the last quarter. Atlas Brown Inc. raised its position in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after purchasing an additional 38 shares during the period. Mather Group LLC. lifted its stake in shares of Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after purchasing an additional 41 shares during the last quarter. Capital Advisors Ltd. LLC grew its holdings in shares of Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after purchasing an additional 43 shares during the period. Finally, Retirement Planning Co of New England Inc. increased its position in shares of Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after purchasing an additional 43 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Thursday. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price objective for the company. Truist Financial boosted their target price on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a report on Friday, April 11th. Finally, StockNews.com upgraded Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Seventeen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $287.76.

Humana Price Performance

HUM traded up $0.75 during midday trading on Thursday, reaching $262.99. 642,323 shares of the company's stock were exchanged, compared to its average volume of 1,669,413. The business's 50-day moving average price is $266.18 and its 200 day moving average price is $270.70. The stock has a market capitalization of $31.74 billion, a PE ratio of 26.43, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. Humana's revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.23 EPS. As a group, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.35%. The ex-dividend date is Friday, June 27th. Humana's payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.